ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016 ACR/ARHP Annual Meeting
    • 2015 ACR/ARHP Annual Meeting
    • 2014 ACR/ARHP Annual Meeting
    • 2013 ACR/ARHP Annual Meeting
    • 2012 ACR/ARHP Annual Meeting
    • 2011 ACR/ARHP Annual Meeting
    • 2010 ACR/ARHP Annual Meeting
    • 2009 ACR/ARHP Annual Meeting
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

Abstracts tagged "tocilizumab and ultrasound"

  • Abstract Number: 558 • 2018 ACR/ARHP Annual Meeting

    Major Reduction of Ultrasound Detected Synovitis during Subcutaneous Tocilizumab Treatment; Results from a Multicenter 24 Weeks Study of Patients with Rheumatoid Arthritis

    Hilde B Hammer1, Inger Marie Jensen Hansen2, Pentti Järvinen3, Marjatta Leirisalo-Repo4, Michael Ziegelasch5, Birte Agular6 and Lene Terslev7, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Rheumatology, Svendborg Hospital, Svendborg, Denmark, 3Rheumatology, Kiljava Medical Research, Kiljavan, Finland, 4Rheumatology, University of Helsinki, Helsinki, Finland, 5Rheumatology, University Hospital, Linköping, Linköping, Sweden, 6Roche, Copenhagen, Denmark, 7Copenhagen Center for Arthritis Research (COPECARE), Center for Rheumatology and Spine Diseases, Rigshospitalet, Centre for Head and Orthopaedics, Rigshospitalet, Glostrup, Denmark

    Background/Purpose: Ultrasound (US) is sensitive for detection of synovitis (assessed by Grey Scale (GS) and power/color Doppler). Presence of Doppler activity is found to predict…
  • Abstract Number: 2868 • 2018 ACR/ARHP Annual Meeting

    Tender Joint Count May Not Reflect Inflammatory Activity in Established Rheumatoid Arthritis Patients; Results from a Longitudinal Study of Tocilizumab

    Hilde B Hammer1, Inger Marie Jensen Hansen2, Pentti Järvinen3, Marjatta Leirisalo-Repo4, Michael Ziegelasch5, Birte Agular6 and Lene Terslev7, 1Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Rheumatology, Svendborg Hospital, Svendborg, Denmark, 3Rheumatology, Kiljava Medical Research, Kiljavan, Finland, 4Rheumatology, University of Helsinki, Helsinki, Finland, 5Rheumatology, University Hospital, Linköping, Linköping, Sweden, 6Roche, Copenhagen, Denmark, 7Rheumatology, Rigshospitalet Glostrup, Copenhagen, Denmark

    Background/Purpose: Tender joints may be caused by non-inflammatory pathologies but are still included in composite scores like CDAI. The present objective was to explore the…
  • Abstract Number: 129 • 2016 ACR/ARHP Annual Meeting

    Ultrasound Is More Reliable Than Inflammatory Parameters (ESR and CRP) to Evaluate Disease Activity in Rheumatoid Arthritis Patients on Tocilizumab Therapy

    Ying-Chou Chen Sr., Division of Rheumatology, Allergy and Immunology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan., YC Chen, Kaohsiung County, Taiwan

    Background/Purpose: The goal of therapy of rheumatoid arthritis(RA) is to achieve a remission or at least low disease activity. Tocilizumab completely interrupt the effect of…
  • Abstract Number: 2604 • 2016 ACR/ARHP Annual Meeting

    Ultrasound and Immunological Changes and Associations after One Year of IL-6/IL- 6R Blockade with Tocilizumab in Rheumatoid Arthritis Patients

    Cesar Diaz-Torne1, Juan Jose De Agustin2, Patricia Moya1, Maria A. Ortiz3, Delia Reina4, Carme Moragues5, Sergi Ros6, Emili Gomez7, Enrique Casado Burgos8, Eli Garcia9, Manel Pujol10, Maria Pilar Lisbona Perez11, Andrés Ponce12, V Torrente13, P. Estrada14, Silvia Vidal3 and ECOCAT group, 1Rheumatology, Hospital Universitari de la Santa Creu i Sant Pau, Barcelona, Spain, 2Rheumatology, Hospital Baix de Llobregat, Barcelona, Spain, 3Institut de Recerca Sant Pau, Barcelona, Spain, 4Rheumatology, Hospital de Sant Joan Despí Moisès Broggi, Barcelona, Spain, 5Rheumatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain, 6Rheumatology, Hospital de Viladecans, Viladecans, Spain, 7Rheumatology, Hospital Clínic, Barcelona, Spain, 8Hospital Universitari Parc Taulí, Sabadell, Spain, 9Rheumatology, Hospital de Mollet, Mollet, Spain, 10Hospital Mútua de Terrassa, Terrassa, Spain, 11Rheumatology, Hospital de Sabadell, Sabadell, Spain, 12Rheumatology. Internal Medicine, Hospital General de Granollers, Granollers, Spain, 13Hospital de L'Hospitalet, L'Hospitalet de Llobregat, Spain, 14Rheumatology, Hospital Moises Broggi, Barcelona, Spain

    Background/Purpose: Management of RA patients has improved in the last two decades in part with the use of ultrasound (US) in daily clinical practice. The…
  • Abstract Number: 466 • 2012 ACR/ARHP Annual Meeting

    Synovialitis Plus Articular Cartilage Monitoring Via Magnetic Resonance Imaging and Ultrasound Under Tocilizumab Therapy in Patients with Rheumatoid Arthritis

    Maria Hoehle1 and Michael Finkenstaedt2, 1Rheumatology, Hamburg, Germany, 2Private Practice for Radiology and Neuroradiology, Hamburg, Germany

    Background/Purpose: To determine remission in RA, recent publications point out the importance of radiological parameters, besides scores like DAS28, TJC, SJC, CrP, patient global assessment,…
  • Abstract Number: 470 • 2012 ACR/ARHP Annual Meeting

    Concomitant Assessment of Clinical and Ultrasound Efficacy and Safety of Tocilizumab in Patients with Moderate to Severe Rheumatoid Arthritis: The Torpedo Study

    Thierry Schaeverbeke1, Philippe Gaudin2, Aleth Perdriger3, Christian Roux4, Muriel Vray5, Stephanie Rouanet6, Ghislaine Steinberg7 and Fabien Etchepare8, 1Service de Rhumatologie, Groupe Hospitalier Pellegrin, Bordeaux, France, 2Rheumatology Department, CHU Hôpital Sud, Grenoble Teaching Hospital, Echirolles, France, 3Rheumatology, Hôpital Sud, Rennes, France, 4Rheumatology, Paris Descartes University, Paris, France, 5Institut Pasteur, Paris, France, 6Medical Department, Roche, Boulogne, France, 7Medical department, Roche, Boulogne, France, 8G.H. Pitié-Salpêtrière, Paris, France

    Background/Purpose: The anti-IL6-R tocilizumab (TCZ), indicated for the treatment of moderate to severe rheumatoid arthritis (RA), has demonstrated its clinical and structural efficacy in phase…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Annual Meeting in Atlanta, Georgia

© COPYRIGHT 2019 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.